tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





DIVTECH kits - Your ready-to-use drug delivery systems

Would you like to be free of the time-consuming constraints linked to delivery vehicle development, due to poor solubility of your molecule, toxicity, poor intracellular delivery, or any other technical hold-backs?

Discover a new technology - Lipid nanoemulsion system

Specifically designed to associate small molecules, peptides and proteins, DIVTECH kits are new ready-to-go solutions to quickly evaluate if your molecule has the desired therapeutic effect at the desired site of action.

  • Easy to use - Few-step protocol to associate your molecule
  • Non-cationic molecule - No need to consider physical characteristics of the molecule
    pI, MW for proteins and peptides or hydrophobicity for the small Molecules
  • Stable - In different biological fluids, sera and cell culture media
    No need for organic solvents
  • Non-toxic and biocompatible - Different cell types and in vivo models
  • Scalable - From lab-scale to GMP production

Easily track the delivery of your molecule of interest, with the fluorescent version of DIVERSA's Lipid Nanoemulsion.

See how and why DIVERSA are opening up a new era in the field of delivery

Download the DIVTECH Application Note

Order your ready-to-use DIVTECH kits

Delivery Control

Small Molecule

Peptides

Proteins

Anionic Proteins & Petides

References

  • Masoumi F et al (2021). Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem. Pharmaceutics 13(9), 1507. 3390/pharmaceutics13091507
  • Díez-Villares et al. (2021). Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging. Int J Nanomedicine 16: 5923–5935. 10.2147/IJN.S316767
  • S. Díez-Villares et al. (2021). Manganese Ferrite Nanoparticles Encapsulated into Vitamin E/Sphingomyelin Nanoemulsions as Contrast Agents for High-Sensitive Magnetic Resonance Imaging. Adv Healthc Mater e2101019. 10.1002/adhm.202101019
  • L. Bouzo et al. (2021). Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer. Sci Rep 11: 17213. 10.1038/s41598-021-96578-z
  • L. Bouzo et al. (2020). In Vitro–In Silico Modeling Approach to Rationally Designed Simple and Versatile Drug Delivery Systems. J. Phys. Chem. B 124, 28, 5788–5800. 10.1021/acs.jpcb.0c02731
  • Nagachinta et al. (2020). Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics 12(2), 189. 10.3390/pharmaceutics12020189